EFFECT OF GLUTATHIONE DEPLETION AND ORAL N-ACETYL-CYSTEINE TREATMENT ON CD4(+) AND CD8(+) CELLS

被引:98
作者
KINSCHERF, R
FISCHBACH, T
MIHM, S
ROTH, S
HOHENHAUSSIEVERT, E
WEISS, C
EDLER, L
BARTSCH, P
DROGE, W
机构
[1] DEUTSCH KREBSFORSCHUNGSZENTRUM, DEPT IMMUNOCHEM, D-69120 HEIDELBERG, GERMANY
[2] DEUTSCH KREBSFORSCHUNGSZENTRUM, DIV BIOMED STAT ANAL, D-69120 HEIDELBERG, GERMANY
[3] UNIV HEIDELBERG, DEPT SPORT MED, HEIDELBERG, GERMANY
关键词
GLUTATHIONE DISULFIDE; MONONUCLEAR CELLS; LYMPHOCYTES;
D O I
10.1096/fasebj.8.6.7909525
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
HIV-infected individuals and SIV-infected rhesus macaques have, on the average, decreased plasma cysteine and cystine concentrations and decreased intracellular glutathione levels. We show that the cysteine supply and the intracellular glutathione levels have a strong influence on the T cell system. A study of healthy human subjects revealed that persons with intracellular glutathione levels of 20-30 nmol/mg protein had significantly higher numbers of CD4(+) T cells than persons with either lower or higher glutathione levels. Persons who moved during a 4-week observation period from the optimal to the suboptimal range (10-20 nmol/mg) experienced, on the average, a 30% decrease in CD4(+) T cell numbers. This decrease was prevented by treatment with N-acetyl-cysteine (NAC). NAC caused this relative increase of CD4(+) T cell numbers in spite of decreasing glutathione levels and not by increasing the glutathione level. Our studies suggest that the immune system may be exquisitely sensitive not only against a cysteine and glutathione deficiency but also against an excess of cysteine.
引用
收藏
页码:448 / 451
页数:4
相关论文
共 22 条
[1]  
BUHL R, 1990, LANCET, V336, P1294
[2]   GLUTATHIONE DEPLETION IN HIV-INFECTED PATIENTS - ROLE OF CYSTEINE DEFICIENCY AND EFFECT OF ORAL N-ACETYLCYSTEINE [J].
DEQUAY, B ;
MALINVERNI, R ;
LAUTERBURG, BH .
AIDS, 1992, 6 (08) :815-819
[3]  
DROGE W, 1986, IMMUNOBIOLOGY, V172, P151
[4]   ABNORMAL AMINO-ACID-CONCENTRATIONS IN THE BLOOD OF PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) MAY CONTRIBUTE TO THE IMMUNOLOGICAL DEFECT [J].
DROGE, W ;
ECK, HP ;
NAHER, H ;
PEKAR, U ;
DANIEL, V .
BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1988, 369 (03) :143-148
[5]   HIV-INDUCED CYSTEINE DEFICIENCY AND T-CELL DYSFUNCTION - A RATIONALE FOR TREATMENT WITH N-ACETYLCYSTEINE [J].
DROGE, W ;
ECK, HP ;
MIHM, S .
IMMUNOLOGY TODAY, 1992, 13 (06) :211-214
[6]   BLOOD ANTIOXIDANT STATUS AND ERYTHROCYTE LIPID-PEROXIDATION FOLLOWING DISTANCE RUNNING [J].
DUTHIE, GG ;
ROBERTSON, JD ;
MAUGHAN, RJ ;
MORRICE, PC .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1990, 282 (01) :78-83
[7]   METABOLIC DISORDER AS EARLY CONSEQUENCE OF SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION IN RHESUS MACAQUES [J].
ECK, HP ;
STAHLHENNIG, C ;
HUNSMANN, G ;
DROGE, W .
LANCET, 1991, 338 (8763) :346-347
[8]   LOW CONCENTRATIONS OF ACID-SOLUBLE THIOL (CYSTEINE) IN THE BLOOD-PLASMA OF HIV-1-INFECTED PATIENTS [J].
ECK, HP ;
GMUNDER, H ;
HARTMANN, M ;
PETZOLDT, D ;
DANIEL, V ;
DROGE, W .
BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1989, 370 (02) :101-108
[9]   T4+ CELL NUMBERS ARE CORRELATED WITH PLASMA GLUTAMATE AND CYSTINE LEVELS - ASSOCIATION OF HYPERGLUTAMATAEMIA WITH IMMUNODEFICIENCY IN DISEASES WITH DIFFERENT ETIOLOGIES [J].
ECK, HP ;
MERTENS, T ;
ROSOKAT, H ;
FATKENHEUER, G ;
POHL, C ;
SCHRAPPE, M ;
DANIEL, V ;
NAHER, H ;
PETZOLDT, D ;
DRINGS, P ;
DROGE, W .
INTERNATIONAL IMMUNOLOGY, 1992, 4 (01) :7-13
[10]   LOW MEMBRANE-TRANSPORT ACTIVITY FOR CYSTINE IN RESTING AND MITOGENICALLY STIMULATED HUMAN LYMPHOCYTE PREPARATIONS AND HUMAN T-CELL CLONES [J].
GMUNDER, H ;
ECK, HP ;
DROGE, W .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1991, 201 (01) :113-117